Printer Friendly
The Free Library
18,914,768 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

NeuroGenesis Reports a Continued Month over Month Increase in Sales of its Nutritional Supplement Known As ''beCALM'd'' which Treats ADHD.


HOUSTON -- "beCALM'd" Has Been Available in Market for 22 Years With No Claims and No Serious Side-Effects

NeuroGenesis neurogenesis /neu·ro·gen·e·sis/ (-jen´e-sis) the development of nervous tissue.

neu·ro·gen·e·sis
n.
Formation of nervous tissue.



neurogenesis

the development of nervous tissue.
, Inc., (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 PK: NEUN) is pleased to announce their patented nutritional supplement known as "beCALM'd" is experiencing a continued month over month increase in sales. This comes at a time when the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 has repeatedly taken commonly used and known drugs sold by major pharmaceuticals off the market or listed them as "dangerous".

NeuroGenesis has been selling their nutritional supplement known as "beCALM'd" for over 22 years with no claims and no significant side-effects. This product was designed specifically to treat Attention Deficit/Hyperactivity Disorders Attention deficit/hyperactivity disorder
A persistent pattern of inattention, hyperactivity and/or impulsiveness; the pattern is more frequent and severe than is typically observed in people at a similar level of development.
 (ADHD Attention-Deficit/Hyperactivity Disorder (ADHD) Definition

Attention-deficit/hyperactivity disorder (ADHD) is a developmental disorder characterized by distractibility, hyperactivity, impulsive behaviors, and the inability to remain focused on tasks or
). According to (neurologist Dr. Fred) Baughman, "500,000 children in the United States were diagnosed with ADHD in 1985 and between 5 and 7 million have been diagnosed today."

NeuroGenesis has determined the steady month over month increase in sales of "BeCALM'd" has been attributed to four factors:

1.) Continued Global Rise of Individuals Diagnosed with ADHD

2.) FDA Aggressively Taking Commonly Used and Known Drugs Off Market or Listing them as "Dangerous"

3.) BeCALM's 22 Year Record of No Claims and No Significant Side-Effects.

4.) Increase in Individuals Switching from ADHD Drugs to Nutritional Supplement Known as BeCalm'd.

Heading into the second half of 2006, NeuroGenesis will begin aggressively marketing BeCALM be·calm  
tr.v. be·calmed, be·calm·ing, be·calms
1. To render motionless for lack of wind: "Across the harbor, a small sailing skiff, becalmed near some reeds, caught the breeze again" 
 in order establish the product as a brand name and a safer alternative to treat ADHD. Currently over 91 million individuals within the United States are taking nutritional and herbal supplements to safely improve their health.

For more information, please visit the website at www.neurogenesis.com or call (281) 557-7877 ext. 101.

Disclaimer: This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of l995 relating to aspects of the Company's operations and strategies. Important factors could occur to cause actual results to differ materially from those described herein. There is a risk that the Company may incur losses. Readers are urged to consider these cautionary statements carefully. Forward-looking statements speak only as of the date of this news release, and the Company disclaims any obligations to update such statements.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 14, 2006
Words:353
Previous Article:Cadwalader Announces Three Special Counsel.
Next Article:Imagin Molecular Corporation Announces Appointment of Chief Executive Officer.
Topics:



Related Articles
Meds may give attention a lasting boost. (research fails to show that stimulant medication has longterm effectiveness in treating children with...
Kids' attention disorder attracts concern.(no definitive treatment, diagnosis, or follow up for sufferers of attention-deficit hyperactivity disorder...
Gene may alter Ritalin's effects in ADHD.(attention-deficit hyperactivity disorder)(Brief Article)
Attention Deficit Hyperactivity Disorder (ADHD) - Questions and Answers.(Pamphlet)
When children with attention-deficit/hyperactivity disorder become adults. (Featured CME Topic: Pediatrics).
Controlling kids: are diet and toxic substances linked to attention deficit disorder? (Your Health).
Micronutrient supplementation shows promise in placebo-controlled Trial.
Globalist threat to vitamins: bureaucrats attached to the United Nations are seeking to deprive millions worldwide of access to nutritional...
Cigarettes and lead linked to attention disorder.(EPIDEMIOLOGY)(Brief article)
Med-start kids: pros, cons of Ritalin for preschool ADHD.(attention-deficit hyperactivity disorder)

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles